Benza, Raymond L <br/><br/>
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.  [electronic resource] 

 -  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation  Sep 2011 
 - 982-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1557-3117 
<br/><br/><label>Standard No.: </label>10.1016/j.healun.2011.03.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antihypertensive Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Dose-Response Relationship, Drug<br/>Epoprostenol--administration & dosage<br/>Familial Primary Pulmonary Hypertension<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--diagnosis<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Treatment Outcome<br/>Vascular Resistance--physiology<br/>Young Adult